We demonstrated some time ago that increased c-Jun expression and AP-1 activation were associated with apoptotic death after VM-26 treatment in drug-sensitive leukemia cells but were attenuated according to the degree of VM-26 resistance [115]. The gene discussed is FOS; the disease is leukemia.